Objective:To evaluate changes in clinicalmarkers of unremitted hyperthyroidism patients after the first 131 I treatment.
目的：探讨第一次1 31 I治疗后甲亢未缓解患者的临床指标变化情况。
2
When we measure those biomarkers we also need link back to those simple measurements we use in daily practice because our biomarkers need to be able to trump those simple clinicalmarkers.
Study the changes of hemostatic molecular markers inacute monoblastic leukemia for elucidate the mechanism of hemorrhage and its clinical significance.